You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

PEPCID Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Pepcid patents expire, and what generic alternatives are available?

Pepcid is a drug marketed by Salix Pharms, Merck, Bausch, J And J Consumer Inc, and Merck Sharp Dohme. and is included in nine NDAs.

The generic ingredient in PEPCID is calcium carbonate; famotidine; magnesium hydroxide. There are two hundred and eighty-two drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the calcium carbonate; famotidine; magnesium hydroxide profile page.

Drug patent expirations by year for PEPCID
Drug Prices for PEPCID

See drug prices for PEPCID

Recent Clinical Trials for PEPCID

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ohio State University Comprehensive Cancer CenterPhase 2/Phase 3
Leidos Life SciencesPhase 2
United States Department of DefensePhase 2

See all PEPCID clinical trials

US Patents and Regulatory Information for PEPCID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Salix Pharms PEPCID famotidine FOR SUSPENSION;ORAL 019527-001 Feb 2, 1987 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020325-001 Apr 28, 1995 OTC Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Bausch PEPCID famotidine TABLET;ORAL 019462-002 Oct 15, 1986 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Merck Sharp Dohme PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER famotidine INJECTABLE;INJECTION 020249-001 Feb 18, 1994 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020902-001 Aug 5, 1999 OTC No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Merck PEPCID RPD famotidine TABLET, ORALLY DISINTEGRATING;ORAL 020752-002 May 28, 1998 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Merck PEPCID famotidine INJECTABLE;INJECTION 019510-001 Nov 4, 1986 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PEPCID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch PEPCID famotidine TABLET;ORAL 019462-001 Oct 15, 1986 ⤷  Try a Trial ⤷  Try a Trial
Bausch PEPCID famotidine TABLET;ORAL 019462-002 Oct 15, 1986 ⤷  Try a Trial ⤷  Try a Trial
Salix Pharms PEPCID famotidine FOR SUSPENSION;ORAL 019527-001 Feb 2, 1987 ⤷  Try a Trial ⤷  Try a Trial
Merck PEPCID famotidine INJECTABLE;INJECTION 019510-001 Nov 4, 1986 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for PEPCID

See the table below for patents covering PEPCID around the world.

Country Patent Number Title Estimated Expiration
Germany 2951675 ⤷  Try a Trial
Philippines 16099 GUANIDINOTHIAZOLE COMPOUNDS,PROCESS FOR PREPARING THEM AND MEDICAL COMPOSITION CONTAINING THEM ⤷  Try a Trial
Japan S55118476 NOVEL AMIDINE DERIVATIVE AND ITS PREPARATION ⤷  Try a Trial
Sweden 7910568 ⤷  Try a Trial
Philippines 15657 GUANIDINOTHIAZOLE COMPOUNDS,PROCESS FOR PREPARATION AND GASTRIC INHIBITING COMPOSITIONS CONTAINING THEM ⤷  Try a Trial
U.S.S.R. 876056 METHOD OF PRODUCING GUANIDINOTHIAZOLE COMPOUNDS ⤷  Try a Trial
United Kingdom 2055800 GUANIDINOTHIAZOLES AND THEIR PREPARATION AND USE ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.